A LinkedIn post from Vektor Medical Inc highlights the company’s planned Rhythm Theater session at HRS2026, featuring several electrophysiologists discussing real‑world clinical experience with non‑invasive ECG localization. The session is scheduled for Saturday, April 25, and is positioned as a forum on how pre‑ and intra‑procedural insights can support case planning, procedural efficiency, and more focused mapping and ablation strategies across various arrhythmias.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post also notes that Vektor Medical will demonstrate its vMap technology at adjacent booths 1531 and 1532 during the event. For investors, this presence at a major electrophysiology conference suggests continued commercial and clinical engagement for vMap, which could support adoption, reinforce relationships with key opinion leaders, and potentially contribute to future revenue growth if the technology gains broader traction in cardiac arrhythmia management.